Yahoo Finance Global Smartphone Market Had Worst Drop Since Virus Outbreak
(Bloomberg) -- Smartphone shipments fell 11% in the first quarter, the worst drop since the coronavirus outbreak, after inflation fears, Russia’s invasion of Ukraine and the Omicron variant derailed an unsteady recovery for the sector.
Most Read from Bloomberg
‘Weak Sauce’: Elon Musk’s 2018 Feud With Saudi Fund Revealed
Anger in Japan as Ukraine Links Emperor Hirohito to Adolf Hitler
Ukraine Latest: Zelenskiy Says Top U.S. Officials to Visit Kyiv
Stocks Tumble as China Lockdowns Rattle Investors: Markets Wrap
Samsung Electronics Co. reclaimed the lead from Apple Inc. with a 24% share, according to Canalys market data, with Chinese vendors Xiaomi Corp., Oppo and Vivo filling out the top five in roughly the same proportion as they did a year ago. The major slowdown was due in part to China’s pursuit of a Covid Zero policy that’s impacted both demand and supply in the world’s biggest smartphone market, with domestic manufacturers struggling to secure components for their entry-level devices, the researchers found.
“Markets saw a spike in Covid-19 cases due to the Omicron variant,” said Canalys Vice President Nicole Peng. “Vendors face major uncertainty due to the Russia-Ukraine war, China’s rolling lockdowns and the threat of inflation. All this added to traditionally slow seasonal demand.”
China’s quarterly production of semiconductors shrank for the first time since early 2019 as consumer electronics demand softened and Covid-triggered lockdowns in regions including Shanghai disrupted output, official figures showed this week.
Component shortages may improve sooner than expected, however, and provide cost relief to manufacturers, Peng said.
Global smartphone demand is likely to be curbed by an inflationary environment, according to Bloomberg Intelligence analyst Woo Jin Ho, who expects 2022 sales of roughly $527 billion, little changed from last year and 4% below IDC’s target.
Most Read from Bloomberg Businessweek
Why Nasal Sprays Are Poised to Be the Next Weapon for Fighting Covid
This Earnings Season Will Be a Weird One for Industrial Companies
Alzheimer’s Trials Exclude Black Patients at ‘Astonishing’ Rate
©2022 Bloomberg L.P.
